AI-based models can outperform human experts at identifying ovarian cancer

FHS
January 2, 2025
10:56 am

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images.

Gene-editing field sees another merger, this time between Chroma Medicine and Nvelop Therapeutics

Two prominent gene-editing startups, Chroma Medicine and Nvelop Therapeutics, said Wednesday they will merge, forming a new company called nChroma Bio. The merger will combine

December 11, 2024

Canada’s Solve FSHD provides $1.4m for rare muscle dystrophy therapy – Pharmaceutical Technology

FSHD is a rare genetic disease that results in progressive muscle degeneration, atrophy, and weakness of selected muscles in the body. Image Credit: Allexxandar /

July 12, 2023

Opinion | Fauci Facepalms Won’t Cut It in the Second Trump Administration

Oxman is an intensive care physician and associate professor of medicine. It was one of the more memorable images of the COVID pandemic. Anthony Fauci,

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.